Crespo, JavierIglesias-García, JulioHinojosa Del Val, Joaquin EGarcía García, FedericoGil de Miguel, ÁngelFernández Carrillo, CarlosAmpuero, JavierPérez-Cuadrado Martínez, Enrique2023-02-082023-02-0820201130-0108http://hdl.handle.net/10668/15439The purpose of this rapid review is to provide an update on the impact of SARS-CoV-2 infection on Gastroenterology and Hepatology departments, our patients, and our new way of working. The gastrointestinal tract and the liver are affected by SARS-CoV-2, especially in patients with immunosuppressive therapies. Patients with liver transplantation should be followed closely. Digestive endoscopy is a high-risk procedure for the transmission of SARS-CoV-2. While the pandemic lasts, we must adapt its indications and promote protective measures for patients and healthcare professionals alike. The COVID-19 pandemic has changed our priorities and the way we work, although we do not know what the repercussions will be after normality is reinstated.enBetacoronavirusCOVID-19Coronavirus InfectionsDigestive SystemDigestive System DiseasesDisease Transmission, InfectiousEndoscopy, Digestive SystemHumansImmunosuppressive AgentsInfection ControlLiver TransplantationPandemicsPneumonia, ViralSARS-CoV-2research article32338017open access10.17235/reed.2020.7128/2020https://doi.org/10.17235/reed.2020.7128/2020